Virology News and Research

Latest Virology News and Research

Study: Higher risk of NHL and Cholangiocarcinoma associated with HBV infection

Study: Higher risk of NHL and Cholangiocarcinoma associated with HBV infection

Investment report on Idenix Pharmaceuticals

Investment report on Idenix Pharmaceuticals

Investment report on Anadys Pharmaceuticals

Investment report on Anadys Pharmaceuticals

Preclinical results of Avila Therapeutics' AVL-181 and AVL-192 presented at EASL Annual Meeting

Preclinical results of Avila Therapeutics' AVL-181 and AVL-192 presented at EASL Annual Meeting

InterMune reports Phase 1b MAD study results of RTV-boosted danoprevir in HCV patients at 45th EASL

InterMune reports Phase 1b MAD study results of RTV-boosted danoprevir in HCV patients at 45th EASL

Findings strengthen promise of SCYNEXIS' SCY-635 for HCV treatment

Findings strengthen promise of SCYNEXIS' SCY-635 for HCV treatment

Novel instrument may help limit spread of diarrhoea-causing bacteria

Novel instrument may help limit spread of diarrhoea-causing bacteria

Promising pharmacokinetic data from Idenix Pharmaceuticals' Phase I study of IDX320 for HCV

Promising pharmacokinetic data from Idenix Pharmaceuticals' Phase I study of IDX320 for HCV

Positive interim data from Idera Pharmaceuticals' Phase 1 trial of IMO-2125 TLR9 agonist presented at 45th EASL

Positive interim data from Idera Pharmaceuticals' Phase 1 trial of IMO-2125 TLR9 agonist presented at 45th EASL

Results from Romark Laboratories' STEALTH C-3 clinical trial presented at EASL Annual Meeting

Results from Romark Laboratories' STEALTH C-3 clinical trial presented at EASL Annual Meeting

First meeting of WHO H1N1 response probe concludes

First meeting of WHO H1N1 response probe concludes

Vertex Pharmaceuticals announces results from Phase 1b clinical trial of VX-222

Vertex Pharmaceuticals announces results from Phase 1b clinical trial of VX-222

SJHS-HC tracks potential influenza cases using SafetySurveillor solution

SJHS-HC tracks potential influenza cases using SafetySurveillor solution

Study finds variation in H1N1 infection risks and antibody levels: JAMA

Study finds variation in H1N1 infection risks and antibody levels: JAMA

Phase 1 clinical trial results of Achillion Pharmaceuticals' ACH-1625 to be presented at EASL meeting

Phase 1 clinical trial results of Achillion Pharmaceuticals' ACH-1625 to be presented at EASL meeting

New York Times examines how developments in India, Nigeria could aid global polio eradication campaign

New York Times examines how developments in India, Nigeria could aid global polio eradication campaign

WHO official says agency struggled to find 'right tempo' for release of H1N1 information

WHO official says agency struggled to find 'right tempo' for release of H1N1 information

Interim results from Pharmasset's phase 2a combination study of PSI-7977 with Pegasys and Copegus for HCV

Interim results from Pharmasset's phase 2a combination study of PSI-7977 with Pegasys and Copegus for HCV

Opinions: Health and living conditions; H1N1, one year later; global water shortages

Opinions: Health and living conditions; H1N1, one year later; global water shortages

NIH awards Corgenix Medical $600,000 grant to develop diagnostic tests for Ebola and Marburg virus

NIH awards Corgenix Medical $600,000 grant to develop diagnostic tests for Ebola and Marburg virus

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.